ARCHERWILL INVESTMENTS INC. ANNOUNCES CHANGES TO HOLDINGS IN MTL CANNABIS CORP.
ARCHERWILL INVESTMENTS INC. ANNOUNCES CHANGES TO HOLDINGS IN MTL CANNABIS CORP.
TORONTO, Dec. 18, 2024 /CNW/ - A joint actor of Archerwill Investments Inc. ("Archerwill") has acquired 270,000 common shares ("Common Shares") of MTL Cannabis Corp. (CSE: MTLC) ("MTL Cannabis" or the "Issuer") on December 17, 2024 at a trade price of $0.24977 per share, for aggregate proceeds of $67,437.50. This represented approximately 0.23% of the issued and outstanding Common Shares of the MTL Cannabis at that time.
多伦多，2024年12月18日 /CNW/ - Archerwill Investments Inc.（“Archerwill”）的联合行为者于2024年12月17日以每股$0.24977的交易价格，购买了270,000股MTL Cannabis Corp.（CSE: MTLC）（“MTL Cannabis”或“发行人”）的普通股（“普通股”），总收益为$67,437.50。这代表了当时MTL Cannabis已发行和流通的普通股的约0.23%。
Following completion of Archerwill's investment in the Issuer on August 4, 2020 pursuant to the terms of a subscription agreement dated July 15, 2020, and prior to the issuances of additional Common Shares by MTL Cannabis and other securities convertible or exchangeable for Common Shares by MTL Cannabis, primarily related to the issuance of Common Shares in connection with the Issuer's acquisition of all of the issued and outstanding shares of Montreal Cannabis Medical Inc. ("MCMI"), completed in two tranches on August 30, 2022 and July 31, 2023 (the "MTL Transaction"), Archerwill beneficially owned or exercised control over: 104,067 Common Shares (on a post consolidation basis following the Issuer's 30-to-1 share consolidation effected by the Issuer on August 16, 2022 (the "Issuer Share Consolidation")), a convertible debenture in aggregate principal amount of $6,500,000, and 4,333,333 warrants (on a post-Issuer Share Consolidation Basis) to purchase Common Shares (such warrants were exchanged for 4,333,333 new warrants to purchase Common Shares in connection with the MTL Transaction, and of which 2,600,000 warrants vested only upon achievement of a volume weighted average trading price threshold following completion of the MTL Transaction, which did not vest and expired in accordance with their terms). This represented approximately 28.3% of the issued and outstanding Common Shares of the MTL Cannabis at the time of Archerwill's investment on August 4, 2020 (assuming Archerwill's conversion and exercise in full of all securities it holds in MTL Cannabis but no other conversions of outstanding securities of MTL Cannabis).
在Archerwill根据2020年7月15日的认购协议于2020年8月4日完成对发行人的投资之前，以及在MTL Cannabis发行其他普通股和可转换或可交换普通股的其他证券之前，主要与发行人完成收购蒙特利尔大麻医疗公司（“MCMI”）的所有已发行和流通股份相关，该收购于2022年8月30日和2023年7月31日分两批完成（“MTL交易”），Archerwill实际拥有或控制：104,067股普通股（在发行人于2022年8月16日实施的30比1股票合并后的基础上（“发行人股票合并”）），一份总本金为$6,500,000的可转换债券，以及4,333,333个Warrants（在发行人股票合并后的基础上）购买普通股（这些Warrants在与MTL交易相关的情况下被交换为4,333,333个新Warrants，购买普通股，其中260万Warrants仅在MTL交易完成后达到成交量加权平均交易价格阈值时归属，但未归属，并根据其条款到期）。这代表了在2020年8月4日Archerwill投资时，MTL Cannabis已发行和流通的普通股的约28.3%（假设Archerwill全额转换和行使其持有的所有MTL Cannabis证券，但不包括其他已发行证券的转换）。
Archerwill and its joint actor now beneficially own or exercise control or direction over: 374,067 Common Shares, a convertible debenture in aggregate principal amount of approximately $5,250,000 (following repayment of principal of approximately $1,250,000 by MTL Cannabis) which is convertible into approximately 13,886,096 Common Shares and 3,907,623 warrants exercisable for 3,907,623 Common Shares (such warrants include 2,174,290 warrants to purchase Common Shares that were issued by MTL Cannabis in connection with repayment of the convertible debenture). This represents approximately 10.7% of the issued and outstanding Common Shares of the MTL Cannabis (assuming Archerwill's conversion and exercise in full of all securities it holds in MTL Cannabis but no other conversions of outstanding securities of MTL Cannabis, but accounting for the issuance of anti-dilution securities issuable to former MCMI shareholders pursuant to the terms of the MTL Transaction). As a result of the issuances of additional Common Shares and other securities convertible or exchangeable for Common Shares by MTL Cannabis, including the issuances primarily related to the issuance of Common Shares in connection with the MTL Transaction and following the acquisition of the Common Shares reported in this press release, Archerwill and its joint actor's total percentage holding in MTL Cannabis has decreased by approximately 17.6%.
Archerwill及其共同行动者目前享有或控制以下权益：374,067股普通股、总本金金额约为5,250,000美元的可转换债券（在MTL大麻股偿还约1,250,000美元本金后）可转换为约13,886,096股普通股，以及可以行使3,907,623股普通股的3,907,623个Warrants（这些Warrants包括由MTL大麻股因偿还可转换债券而发行的2,174,290个购买普通股的Warrants）。这代表了MTL大麻股已发行和流通的普通股的约10.7%（假设Archerwill完全转换和行使其在MTL大麻股所持有的所有证券，但不包括MTL大麻股其他已发行证券的转换，同时考虑到根据MTL交易条款向前MCMI股东发行的防稀释证券）。由于MTL大麻股增发了额外的普通股和其他可转换或可交换为普通股的证券，包括与MTL交易相关的普通股发行，以及在本新闻稿中报道的普通股的收购之后，Archerwill及其共同行动者在MTL大麻股的整体持股比例已下降约17.6%。
Archerwill's joint actor acquired the Common Shares of MTL Cannabis through the facilities of the Canadian Securities Exchange for investment purposes. Presently, Archerwill and its joint actor have no intention of acquiring any securities of MTL Cannabis. Archerwill or its joint actor may acquire ownership of or control over further securities of MTL Cannabis in the future depending upon market circumstances. Increase or decrease in ownership of securities of MTL Cannabis will depend on numerous conditions, including the price of the Common Shares and general market conditions.
Archerwill的共同行动者通过加拿大证券交易所的设施收购了MTL大麻股的普通股，目的是投资。目前，Archerwill及其共同行动者没有收购MTL大麻股任何证券的意图。根据市场情况，Archerwill或其共同行动者未来可能会进一步获得MTL大麻股的证券的所有权或控制权。对MTL大麻股证券的增减持将取决于多个条件，包括普通股的价格及整体市场状况。
The head office of MTL Cannabis is located at 1773 Bayly Street, Pickering, ON, L1W 2Y7.
MTL大麻股的总部位于安大略省皮克林1773 Bayly街，邮政编码L1W 2Y7。
An early warning report relating to this transaction will be filed on the System for Electronic Data Analysis and Retrieval + ("SEDAR+") under MTL Cannabis's profile and can be viewed at .
与该交易相关的早期警示报告将在电子数据分析和检索系统（"SEDAR+"）下以MTL大麻股的档案提交，您可以查看。 .
SOURCE Archerwill Investments Inc.
来源：Archerwill Investments Inc.
